Perlepe Garifallia, Varsamas Charalampos, Petinaki Efthymia, Antonopoulos Dionysios, Daniil Zoe, Gourgoulianis Konstantinos I
Department of Respiratory Medicine, Faculty of Medicine, University of Thessaly, 41110 Larissa, Greece.
Department of Microbiology, University Hospital of Larissa, 41110 Larissa, Greece.
J Pers Med. 2021 Aug 30;11(9):864. doi: 10.3390/jpm11090864.
(1) Background: Malignant (MPE), parapneumonic (PPE) and tuberculous (TPE) pleural effusions constitute common causes of pleurisy. Discriminating among them is usually challenging. C-reactive protein (CRP) and adenosine deaminase (ADA) pleural levels (p-CRP, p-ADA) have been used as differentiators in many studies showing promising results. This study aims to evaluate the diagnostic value of p-CRP, p-ADA levels and their combination among the three categories. (2) Methods: A prospective study of 100 patients with MPE ( = 59), PPE ( = 34) and TPE ( = 7) from a single centre was performed. p-CRP levels were evaluated between PPE and non-PPE and between complicated (CPPE) and non-complicated PPE. ADA levels were also measured to classify patients among MPE and non- MPE. Eventually, the combination of p-CRP and p-ADA values was used as a discrimination factor among PPE, MPE and TPE. (3) Results: ROC analysis revealed that p-CRP with a cut-off value: 4.4 mg/dL can successfully differentiate PPE (AUC = 0.998). The cut-off level of 10 mg/dL can predict CPPE with sensitivity: 63%, specificity: 71.4%, positive predictive value (PPV): 89%, and negative predictive value (NPV): 33%. Furthermore, patients with ADA levels ≤ 32 U/L were more likely to belong to the malignant group sensitivity: 93%, specificity: 78%, PPV: 85.9%, and NPV: 88.9%. Discriminant analysis showed that the combination of p-CRP and p-ADA levels can discriminate PPE, MPE and TPE in 93% of cases. (4) Conclusion: This study provides evidence that p-CRP and p-ADA levels could be possibly used in clinal practice in order to establish a diagnosis among MPE, PPE and TPE.
(1) 背景:恶性胸腔积液(MPE)、类肺炎性胸腔积液(PPE)和结核性胸腔积液(TPE)是胸膜炎的常见病因。对它们进行鉴别通常具有挑战性。在许多研究中,C反应蛋白(CRP)和腺苷脱氨酶(ADA)的胸腔积液水平(p-CRP、p-ADA)已被用作鉴别指标,显示出有前景的结果。本研究旨在评估p-CRP、p-ADA水平及其联合检测在这三种类型胸腔积液中的诊断价值。(2) 方法:对来自单一中心的100例MPE患者(n = 59)、PPE患者(n = 34)和TPE患者(n = 7)进行了一项前瞻性研究。评估了PPE与非PPE之间以及复杂性类肺炎性胸腔积液(CPPE)与非复杂性PPE之间的p-CRP水平。还测量了ADA水平以对MPE和非MPE患者进行分类。最终,将p-CRP和p-ADA值的联合检测用作PPE、MPE和TPE之间的鉴别因素。(3) 结果:ROC分析显示,截断值为4.4 mg/dL的p-CRP能够成功鉴别PPE(AUC = 0.998)。截断水平为10 mg/dL可预测CPPE,敏感性为63%,特异性为71.4%,阳性预测值(PPV)为89%,阴性预测值(NPV)为33%。此外,ADA水平≤32 U/L的患者更可能属于恶性组,敏感性为93%,特异性为78%,PPV为85.9%,NPV为88.9%。判别分析表明,p-CRP和p-ADA水平的联合检测在93%的病例中能够鉴别PPE、MPE和TPE。(4) 结论:本研究提供了证据表明,p-CRP和p-ADA水平可能在临床实践中用于在MPE、PPE和TPE之间建立诊断。